S.C. Ropharma S.A. (BVB:RPH)

S.C. Ropharma Balance Sheet

Financials in millions RON. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	48.63	19.9	16.51	15.42	10.66	14.66
Cash & Short-Term Investments	48.63	19.9	16.51	15.42	10.66	14.66
Cash Growth	144.34%	20.52%	7.06%	44.70%	-27.28%	27.25%
Accounts Receivable	324.07	323.12	252.48	258.74	204.33	208.8
Other Receivables	8.65	9.83	11.39	10.07	18.68	10.58
Receivables	332.72	332.96	263.88	268.81	223.01	219.38
Inventory	224.55	227.41	170.06	159.79	130.2	114.72
Prepaid Expenses	2.57	1.47	1.42	1	1.06	0.81
Other Current Assets	24.85	19.85	0.17	0.38	0.17	10.12
Total Current Assets	633.32	601.6	452.05	445.4	365.09	359.69
Property, Plant & Equipment	274.37	270.62	288.14	259.76	243.25	235.15
Long-Term Investments	0	0	0	0	0	0.15
Goodwill	23.86	23.86	23.86	23.86	23.86	24.31
Other Intangible Assets	44.9	35.85	30.13	28.13	22.7	21.58
Other Long-Term Assets	14.67	15.83	13.6	13.1	12.43	10.3
Total Assets	991.12	947.76	807.78	770.25	667.34	651.17
Accounts Payable	521.02	497.19	365.49	363.9	290.03	289.08
Accrued Expenses	6.7	7.99	11.28	10.64	9.36	4.23
Short-Term Debt	39.52	36.35	38.5	38.81	33.99	39.9
Current Portion of Long-Term Debt	10.99	8.93	14.92	12.21	13.53	15.3
Current Portion of Leases	12.26	11.25	10.85	10.86	9.45	8.69
Current Income Taxes Payable	4.48	4.13	-	0.62	0.54	0
Current Unearned Revenue	0.25	4.83	0.84	0.19	0.25	0.27
Other Current Liabilities	0.15	0.26	3.68	4.13	2.78	0.9
Total Current Liabilities	595.37	570.93	445.55	441.36	359.93	358.38
Long-Term Debt	30.65	22.5	17.02	26.22	27.34	35.72
Long-Term Leases	90.71	83.4	82.79	60.18	52.49	46.36
Long-Term Deferred Tax Liabilities	11.96	11.59	10.56	9	7.99	8.83
Other Long-Term Liabilities	-0	-	-0	-0	-0	0
Total Liabilities	728.7	688.42	555.92	536.76	447.75	449.29
Common Stock	51.13	51.13	51.13	51.13	51.13	51.13
Additional Paid-In Capital	2.02	2.02	2.02	2.02	2.02	2.02
Retained Earnings	139.75	135.44	135.55	135.6	56.73	49.35
Treasury Stock	-	-	-	-	-0.13	-0.15
Comprehensive Income & Other	54.81	56.64	51.39	42.84	102.72	95.52
Total Common Equity	247.7	245.23	240.08	231.59	212.47	197.87
Minority Interest	14.72	14.12	11.77	1.91	7.12	4
Shareholders' Equity	262.43	259.34	251.85	233.49	219.59	201.87
Total Liabilities & Equity	991.12	947.76	807.78	770.25	667.34	651.17
Total Debt	184.12	162.42	164.08	148.28	136.79	145.98
Net Cash (Debt)	-135.49	-142.52	-147.57	-132.86	-126.13	-131.32
Net Cash Per Share	-0.27	-0.28	-0.29	-0.26	-0.25	-0.26
Filing Date Shares Outstanding	511.27	511.27	511.27	511.27	511.27	509.74
Total Common Shares Outstanding	511.27	511.27	511.27	511.27	511.27	509.74
Working Capital	37.95	30.67	6.5	4.05	5.17	1.31
Book Value Per Share	0.48	0.48	0.47	0.45	0.42	0.39
Tangible Book Value	178.94	185.52	186.09	179.6	165.91	151.98
Tangible Book Value Per Share	0.35	0.36	0.36	0.35	0.32	0.30
Land	25.36	25.5	35.39	31.9	29.28	27.58
Buildings	119.45	118.3	120.63	111.2	107.26	104.78
Machinery	145.43	140.12	134.1	128.6	120.64	115.91
Construction In Progress	8.77	6.48	5.6	4.85	4.33	1.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.